Toward a Comprehensive Understanding of Obstructive Hypertrophic Cardiomyopathy
Ahmad Masri, MD, MS
doaj +1 more source
Hereditary transthyretin amyloid cardiomyopathy caused by the rare TTR p.Ser43Asn variant in an Asian family: a case report. [PDF]
Song B +8 more
europepmc +1 more source
Best practices in specialized hypertrophic cardiomyopathy centers in the United States: a survey of cardiologists, nurses, pharmacists, patients, and patient advocates. [PDF]
Maron M, Steeves B, Wang A.
europepmc +1 more source
Reply: Methodological Considerations on Targeted Polymer Embolization in Obstructive Hypertrophic Cardiomyopathy. [PDF]
Filho EM +4 more
europepmc +1 more source
Daniele Massera, Mark V. Sherrid
doaj +1 more source
Hypertrophic cardiomyopathy in cats: clinical prevalence, risk factors, and outcomes of arterial thromboembolism in a referral population in Tehran, Iran (2020-2024). [PDF]
Jalilian M +8 more
europepmc +1 more source
Long-term clinical benefit of mavacamten for hypertrophic cardiomyopathy in a patient with <i>RAF1</i>-associated Noonan syndrome-case report. [PDF]
Seghers HM +4 more
europepmc +1 more source
Cardiovascular magnetic resonance-derived left atrial parameters for assessing diastolic dysfunction and prognosis in hypertrophic cardiomyopathy. [PDF]
Liao W +6 more
europepmc +1 more source
Novel compound heterozygous mutations in <i>KLHL24</i>-induced recessive inherited hypertrophic cardiomyopathy: a case report. [PDF]
Zhou W, Wang X, Yang J, Liao Y.
europepmc +1 more source
Trametinib Therapy for Hypertrophic Cardiomyopathy and Pulmonary Hypertension in a Child With RAF1-Related Noonan Syndrome (p.Ser257Leu): A Case Report. [PDF]
Nilsson CN +8 more
europepmc +1 more source

